Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPGS | Q05932 | 3/20 | 0.86 |
| ▸ | DHFR | P00374 | 3/20 | 0.86 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.86 |
| ▸ | TLR4 | O00206 | 1/20 | 0.86 |
| ▸ | MEN1 | O00255 | 1/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.86 |
| ▸ | LMNA | P02545 | 1/20 | 0.86 |
| ▸ | TP53 | P04637 | 1/20 | 0.86 |
| ▸ | TYMS | P04818 | 1/20 | 0.86 |
| ▸ | GLA | P06280 | 1/20 | 0.86 |
| ▸ | POLB | P06746 | 1/20 | 0.86 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.86 |
| ▸ | MAPT | P10636 | 1/20 | 0.86 |
| ▸ | FOLR2 | P14207 | 1/20 | 0.86 |
| ▸ | FOLR1 | P15328 | 1/20 | 0.86 |
| ▸ | HPGD | P15428 | 1/20 | 0.86 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.86 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.86 |
| ▸ | GART | P22102 | 1/20 | 0.86 |
| ▸ | APEX1 | P27695 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methopterine SCHEMBL6907131 | 1.00 | FPGS (0.86) | FPGSDHFRKDM4ETLR4MEN1 | |
| Methopterine SCHEMBL10658766 | 0.99 | FPGS (0.84) | FPGSDHFRKDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL9736207 | 0.97 | DHFR (0.92) | FPGSDHFRKDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL2301949 | 0.92 | DHFR (1.00) | FPGSDHFRKDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL3712 | 0.92 | DHFR (1.00) | FPGSDHFRKDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL16013534 | 0.92 | DHFR (1.00) | FPGSDHFRKDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL171251 | 0.92 | DHFR (1.00) | FPGSDHFRKDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL20548444 | 0.92 | DHFR (1.00) | FPGSDHFRKDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL3711 | 0.92 | DHFR (1.00) | FPGSDHFRKDM4ETLR4MEN1 | |
| SCHEMBL13524540 | 0.92 | DHFR (0.87) | FPGSDHFRKDM4ETLR4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5455 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091124-A1 | CLICK-TO-RELEASE ON PROTEINS AND PEPTIDES | VALANX BIOTECH GMBH (AT) | 2026-04-02 | — | — | US | claimed |
| EP-4701667-A1 | TROP2 BINDERS AND CONJUGATES THEREOF | Merck Sharp & Dohme LLC (US) | 2026-03-04 | — | — | EP | claimed |
| EP-4603107-A1 | BIOORTHOGONAL, ANILINIUM BASED CLEAVABLE TETRAZINES | University of Copenhagen (DK) | 2025-08-20 | — | — | EP | claimed |
| EP-4590342-A1 | CLICK-TO-RELEASE ON PROTEINS AND PEPTIDES | VALANX Biotech GmbH (AT) | 2025-07-30 | — | — | EP | claimed |
| US-20250235567-A1 | AGENTS FOR TREATMENT OF ENDOMETRIOSIS AND OTHER BENIGN GYNECOLOGICAL NEOPLASMS | Universitat Zürich (CH) | 2025-07-24 | — | — | US | claimed |
| WO-2025122699-A1 | CDC7 INHIBITOR COMBINATIONAL THERAPY | Lin Bioscience, Inc. (TW) | 2025-06-12 | — | — | WO | claimed |
| US-20250172563-A1 | MATERIALS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CANCER | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2025-05-29 | — | — | US | claimed |
| US-20250090495-A1 | CDC7 Inhibitor Combinational Therapy | Lin Bioscience, Inc. (TW) | 2025-03-20 | — | — | US | claimed |
| EP-4507784-A1 | AGENTS FOR TREATMENT OF ENDOMETRIOSIS AND OTHER BENIGN GYNECOLOGICAL NEOPLASMS | Universität Zürich (CH) | 2025-02-19 | — | — | EP | claimed |
| WO-2024226410-A1 | TROP2 BINDERS AND CONJUGATES THEREOF | MERCK SHARP & DOHME LLC (US) | 2024-10-31 | — | — | WO | claimed |
| EP-0855910-A1 | CONJUGATES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | Merck & Co., Inc. (US) | 1998-08-05 | — | — | EP | claimed |
| EP-0853483-A1 | NOVEL PEPTIDES | Merck & Co., Inc. (US) | 1998-07-22 | — | — | EP | claimed |
| WO-1998018493-A2 | CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER | MERCK & CO., INC. (US) | 1998-05-07 | — | — | WO | claimed |
| WO-1998010651-A1 | CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER | MERCK & CO., INC. (US) | 1998-03-19 | — | — | WO | claimed |
| EP-0771209-A2 | NOVEL PEPTIDES | Merck & Co., Inc. (a New Jersey corp.) (US) | 1997-05-07 | — | — | EP | claimed |
| WO-1997014416-A1 | CONJUGATES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | claimed |
| WO-1997012624-A1 | NOVEL PEPTIDES | MERCK & CO., INC. (US) | 1997-04-10 | — | — | WO | claimed |
| WO-1996000503-A1 | NOVEL PEPTIDES | MERCK & CO., INC. (US) | 1996-01-11 | — | — | WO | claimed |
| EP-0225823-B1 | PROCESS FOR THE PREPARATION OF PTERIDINE DERIVATIVES | RHONE-POULENC SANTE (FR) | 1990-01-31 | — | — | EP | claimed |
| US-4767859-A | Process for the preparation of pteridine derivatives | RHONE-POULENC SANTE (FR) | 1988-08-30 | — | — | US | claimed |